Moore Capital Management »

Arcutis Biotherapeutics shares owned by Moore Capital Management

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Moore Capital Management from 13F filings

Historical chart of Moore Capital Management investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Moore Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Moore Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $198k 20k 9.91

More positions owned by Moore Capital Management

Amazon (AMZN)
salesforce (CRM)
Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Energy (XLE)
Microsoft Corporation (MSFT)
Vertiv Holdings Com Cl A (VRT)
Digital Realty Trust (DLR)
Ally Financial (ALLY)
Freeport-mcmoran CL B (FCX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Vaneck Etf Trust Semiconductr Etf (SMH)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Uber Technologies (UBER)

View all positions for Moore Capital Management

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Frazier Life Sciences Management
Suvretta Capital Management
Rubric Capital Management
BlackRock
Vanguard Group
Franklin Resources
Morgan Stanley
Ensign Peak Advisors
Citadel Advisors
Cormorant Asset Management
Bain Capital Life Sciences Investors
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Farallon Capital Management

View all funds holding Arcutis Biotherapeutics